Premium
Cancer Treatment: Dual‐Wavelength Irradiation and Dox Delivery for Cancer Cell Ablation with Photocatalytic Pr Doped TiO 2 /NGO Hybrid Nanocomposite (Adv. Healthcare Mater. 12/2015)
Author(s) -
Jang Hongje,
Choi MyungHo,
Yim Yeajee,
Kim YoungKwan,
Min DalHee
Publication year - 2015
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201570070
Subject(s) - photothermal therapy , materials science , photocatalysis , nanocomposite , cancer cell , nanomaterials , graphene , nanotechnology , cancer , titanium dioxide , doping , cancer therapy , optoelectronics , composite material , medicine , chemistry , catalysis , biochemistry
A grand slam in cancer therapy: On page 1833 Dal‐Hee Min and co‐workers describe how they designed a hybrid nanomaterial with triple action modes: chemo, photothermal and photodynamic. This powerful cancer therapeutic, that showed good results in human cancer cells, is based on graphene oxide, the surface of which is covered with praseodymium doped titanium dioxide.